<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01550016</url>
  </required_header>
  <id_info>
    <org_study_id>281803 (EU FP7-HEALTH-2011)</org_study_id>
    <nct_id>NCT01550016</nct_id>
  </id_info>
  <brief_title>International Research Consortium on Dengue Risk Assessment, Management, and Surveillance</brief_title>
  <acronym>IDAMS</acronym>
  <official_title>Clinical Evaluation of Dengue and Identification of Risk Factors for Severe Disease (WP1)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Heidelberg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Heidelberg Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improvements in diagnosis of dengue fever and prediction of which patients will get more
      severe disease are urgently needed to improve the treatment of patients with dengue. This is
      very important in places with many people who suffer from dengue but have limited health care
      resources. This study will enroll patients with fever which may be caused by dengue in 6
      countries with high incidence of dengue over two continents (Brazil, Cambodia, El Salvador,
      Indonesia, Malaysia and Vietnam). All patients will be followed by a doctor with blood tests
      and exams until they recover. Symptoms and laboratory tests will be followed so that the
      cause of fever can be determined. For patients who have dengue, the investigators will look
      for symptoms and tests which indicate more serious disease. This study will help to determine
      how to identify patients with dengue fever based on symptoms and simple laboratory tests and
      those who will get more serious disease. It will also help to define a more standardized
      management of patients with dengue fever.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Improvements in clinical diagnosis of dengue and risk prediction for severe disease are
      urgently needed to improve overall clinical care, especially in settings with a high case
      burden where appropriate allocation of limited resources is crucial to outcome. In this work
      package 10,000 outpatients with undifferentiated fever, consistent with possible dengue, will
      be recruited within 3 days of fever onset in 6 endemic countries (Brazil, Cambodia, El
      Salvador, Indonesia, Malaysia and Vietnam), and will be followed daily until full recovery.
      Clinical features and simple laboratory parameters differentiating dengue from other febrile
      illness will be identified, and, among those with confirmed dengue, risk factors for
      progression to more severe disease will be evaluated. As well as contributing to the
      development of diagnostic and prognostic algorithms the clinical cohort has considerable
      potential towards standardisation of procedures for dengue management and reporting.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hospitalization or administration of IV fluid</measure>
    <time_frame>14 days</time_frame>
    <description>Proportion of dengue patients hospitalized or treated with IV fluids within 14 days of enrollment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development of severe disease</measure>
    <time_frame>14 days</time_frame>
    <description>Development of severe disease according to the 2009 WHO Dengue classification within 14 days of enrollment.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">7411</enrollment>
  <condition>Dengue Fever</condition>
  <arm_group>
    <arm_group_label>Febrile Patients</arm_group_label>
    <description>Observation of patients with possible dengue fever in the early phase of disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Clinical follow-up and laboratory investigations.</description>
    <arm_group_label>Febrile Patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Febrile patients presenting to outpatient clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;= 5 years of age

          -  fever for less than 72 hours

        Exclusion Criteria:

          -  presence of localizing signs suggestive of another diagnosis

          -  not likely to come back for daily follow-up

          -  complications or signs of severe disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas JÃ¤nisch</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Centre for Diarrhoeal Diseases</name>
      <address>
        <city>Dhaka</city>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Universidade Estadual do Ceara</name>
      <address>
        <city>Fortaleza</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Oswaldo Cruz (FIOCRUZ)</name>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angkor Hospital for Children</name>
      <address>
        <city>Siem Reap</city>
        <country>Cambodia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital National de Ninos Benjamin Bloom</name>
      <address>
        <city>San Salvador</city>
        <country>El Salvador</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gadjah Madah University</name>
      <address>
        <city>Yogyakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Malaya Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad de Carabobo</name>
      <address>
        <city>Valencia</city>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford University Clinical Research Unit</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
    <country>Brazil</country>
    <country>Cambodia</country>
    <country>El Salvador</country>
    <country>Indonesia</country>
    <country>Malaysia</country>
    <country>Venezuela</country>
    <country>Vietnam</country>
  </location_countries>
  <link>
    <url>http://www.idams.eu</url>
    <description>IDAMS consortium</description>
  </link>
  <link>
    <url>http://www.klinikum.uni-heidelberg.de/Sektion-Klinische-Tropenmedizin.5489.0.html</url>
    <description>Section Clinical Tropical Medicine, Heidelberg University Medical Center, Germany</description>
  </link>
  <link>
    <url>http://www.oucru.org</url>
    <description>Oxford University Clinical Research Unit, Viet Nam</description>
  </link>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2012</study_first_submitted>
  <study_first_submitted_qc>March 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2012</study_first_posted>
  <last_update_submitted>October 10, 2016</last_update_submitted>
  <last_update_submitted_qc>October 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Heidelberg Medical Center</investigator_affiliation>
    <investigator_full_name>Thomas Jaenisch</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>dengue warning signs</keyword>
  <keyword>latin america</keyword>
  <keyword>south east asia</keyword>
  <keyword>other febrile illnesses</keyword>
  <keyword>dengue classification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dengue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

